APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prostacyclin

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

Selected research

Market Analysis & Forecast

Global Prostacyclin Market Analysis and Forecast 2026-2032

Report ID 174029280226 December 2025199 pages

Choose your research edition.

Industry ResearchProstacyclin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostacyclin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Prostacyclin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostacyclin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostacyclin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.

United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.

North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.

Read the full market overview

In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.

This report presents an overview of global market for Prostacyclin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prostacyclin, also provides the sales of main regions and countries. Of the upcoming market potential for Prostacyclin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostacyclin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prostacyclin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prostacyclin sales, projected growth trends, production technology, application and end-user industry.

Prostacyclin Segment by Company

United Therapeutics

Actelion (J & J)

GSK

Teva

Toray

Tide Pharma

Bayer AG

Prostacyclin Segment by Type

Epoprostenol Sodium

Treprostinil

Iloprost

Beraprost Sodium

Prostacyclin Segment by Application

For Injection

For Oral

For Inhalation

Prostacyclin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prostacyclin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostacyclin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostacyclin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Epoprostenol Sodium Major Manufacturers Table 3. Treprostinil Major Manufacturers Table 4. Iloprost Major Manufacturers Table 5. Beraprost Sodium Major Manufacturers Table 6. Global Prostacyclin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. For Injection Major Manufacturers Table 8. For Oral Major Manufacturers Table 9. For Inhalation Major Manufacturers Table 10. Prostacyclin Industry Trends Table 11. Prostacyclin Industry Drivers Table 12. Prostacyclin Industry Opportunities and Challenges Table 13. Prostacyclin Industry Restraints Table 14. Global Prostacyclin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Prostacyclin Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Prostacyclin Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Prostacyclin Revenue Market Share by Region (2021-2026) Table 18. Global Prostacyclin Revenue Market Share by Region (2027-2032) Table 19. Global Prostacyclin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Unit) Table 20. Global Prostacyclin Sales by Region (2021-2026) & (K Unit) Table 21. Global Prostacyclin Sales by Region (2027-2032) & (K Unit) Table 22. Global Prostacyclin Sales Market Share by Region (2021-2026) Table 23. Global Prostacyclin Sales Market Share by Region (2027-2032) Table 24. Global Prostacyclin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prostacyclin Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Prostacyclin Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Prostacyclin Sales Market Share by Manufacturers (2021-2026) Table 28. Global Prostacyclin Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 29. Global Prostacyclin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Prostacyclin Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Prostacyclin Manufacturers, Product Type & Application Table 32. Global Prostacyclin Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Prostacyclin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Prostacyclin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Prostacyclin Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Prostacyclin Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Prostacyclin Revenue Market Share by Type (2021-2026) Table 39. Global Prostacyclin Revenue Market Share by Type (2027-2032) Table 40. Global Prostacyclin Sales by Type 2021 VS 2025 VS 2032 (K Unit) Table 41. Global Prostacyclin Sales by Type (2021-2026) & (K Unit) Table 42. Global Prostacyclin Sales by Type (2027-2032) & (K Unit) Table 43. Global Prostacyclin Sales Market Share by Type (2021-2026) Table 44. Global Prostacyclin Sales Market Share by Type (2027-2032) Table 45. Global Prostacyclin Price by Type (2021-2026) & (USD/Unit) Table 46. Global Prostacyclin Price by Type (2027-2032) & (USD/Unit) Table 47. Global Prostacyclin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prostacyclin Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Prostacyclin Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Prostacyclin Revenue Market Share by Application (2021-2026) Table 51. Global Prostacyclin Revenue Market Share by Application (2027-2032) Table 52. Global Prostacyclin Sales by Application 2021 VS 2025 VS 2032 (K Unit) Table 53. Global Prostacyclin Sales by Application (2021-2026) & (K Unit) Table 54. Global Prostacyclin Sales by Application (2027-2032) & (K Unit) Table 55. Global Prostacyclin Sales Market Share by Application (2021-2026) Table 56. Global Prostacyclin Sales Market Share by Application (2027-2032) Table 57. Global Prostacyclin Price by Application (2021-2026) & (USD/Unit) Table 58. Global Prostacyclin Price by Application (2027-2032) & (USD/Unit) Table 59. United Therapeutics Company Information Table 60. United Therapeutics Business Overview Table 61. United Therapeutics Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 62. United Therapeutics Prostacyclin Product Portfolio Table 63. United Therapeutics Recent Development Table 64. Actelion (J & J) Company Information Table 65. Actelion (J & J) Business Overview Table 66. Actelion (J & J) Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Actelion (J & J) Prostacyclin Product Portfolio Table 68. Actelion (J & J) Recent Development Table 69. GSK Company Information Table 70. GSK Business Overview Table 71. GSK Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. GSK Prostacyclin Product Portfolio Table 73. GSK Recent Development Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Teva Prostacyclin Product Portfolio Table 78. Teva Recent Development Table 79. Toray Company Information Table 80. Toray Business Overview Table 81. Toray Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Toray Prostacyclin Product Portfolio Table 83. Toray Recent Development Table 84. Tide Pharma Company Information Table 85. Tide Pharma Business Overview Table 86. Tide Pharma Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Tide Pharma Prostacyclin Product Portfolio Table 88. Tide Pharma Recent Development Table 89. Bayer AG Company Information Table 90. Bayer AG Business Overview Table 91. Bayer AG Prostacyclin Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Bayer AG Prostacyclin Product Portfolio Table 93. Bayer AG Recent Development Table 94. North America Prostacyclin Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Prostacyclin Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Prostacyclin Sales by Type (2021-2026) & (K Unit) Table 97. North America Prostacyclin Sales by Type (2027-2032) & (K Unit) Table 98. North America Prostacyclin Sales Price by Type (2021-2026) & (USD/Unit) Table 99. North America Prostacyclin Sales Price by Type (2027-2032) & (USD/Unit) Table 100. North America Prostacyclin Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Prostacyclin Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Prostacyclin Sales by Application (2021-2026) & (K Unit) Table 103. North America Prostacyclin Sales by Application (2027-2032) & (K Unit) Table 104. North America Prostacyclin Sales Price by Application (2021-2026) & (USD/Unit) Table 105. North America Prostacyclin Sales Price by Application (2027-2032) & (USD/Unit) Table 106. North America Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Prostacyclin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. North America Prostacyclin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. North America Prostacyclin Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 110. North America Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 111. North America Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 112. North America Prostacyclin Sales Price by Country (2021-2026) & (USD/Unit) Table 113. North America Prostacyclin Sales Price by Country (2027-2032) & (USD/Unit) Table 114. United States Prostacyclin Revenue (2021-2032) & (US$ Million) Table 115. Canada Prostacyclin Revenue (2021-2032) & (US$ Million) Table 116. Mexico Prostacyclin Revenue (2021-2032) & (US$ Million) Table 117. Europe Prostacyclin Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Prostacyclin Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Prostacyclin Sales by Type (2021-2026) & (K Unit) Table 120. Europe Prostacyclin Sales by Type (2027-2032) & (K Unit) Table 121. Europe Prostacyclin Sales Price by Type (2021-2026) & (USD/Unit) Table 122. Europe Prostacyclin Sales Price by Type (2027-2032) & (USD/Unit) Table 123. Europe Prostacyclin Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Prostacyclin Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Prostacyclin Sales by Application (2021-2026) & (K Unit) Table 126. Europe Prostacyclin Sales by Application (2027-2032) & (K Unit) Table 127. Europe Prostacyclin Sales Price by Application (2021-2026) & (USD/Unit) Table 128. Europe Prostacyclin Sales Price by Application (2027-2032) & (USD/Unit) Table 129. Europe Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Prostacyclin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. Europe Prostacyclin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. Europe Prostacyclin Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 133. Europe Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 134. Europe Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 135. Europe Prostacyclin Sales Price by Country (2021-2026) & (USD/Unit) Table 136. Europe Prostacyclin Sales Price by Country (2027-2032) & (USD/Unit) Table 137. Germany Prostacyclin Revenue (2021-2032) & (US$ Million) Table 138. France Prostacyclin Revenue (2021-2032) & (US$ Million) Table 139. U.K. Prostacyclin Revenue (2021-2032) & (US$ Million) Table 140. Italy Prostacyclin Revenue (2021-2032) & (US$ Million) Table 141. Russia Prostacyclin Revenue (2021-2032) & (US$ Million) Table 142. Spain Prostacyclin Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Prostacyclin Revenue (2021-2032) & (US$ Million) Table 144. Switzerland Prostacyclin Revenue (2021-2032) & (US$ Million) Table 145. Sweden Prostacyclin Revenue (2021-2032) & (US$ Million) Table 146. Poland Prostacyclin Revenue (2021-2032) & (US$ Million) Table 147. China Prostacyclin Revenue by Type (2021-2026) & (US$ Million) Table 148. China Prostacyclin Revenue by Type (2027-2032) & (US$ Million) Table 149. China Prostacyclin Sales by Type (2021-2026) & (K Unit) Table 150. China Prostacyclin Sales by Type (2027-2032) & (K Unit) Table 151. China Prostacyclin Sales Price by Type (2021-2026) & (USD/Unit) Table 152. China Prostacyclin Sales Price by Type (2027-2032) & (USD/Unit) Table 153. China Prostacyclin Revenue by Application (2021-2026) & (US$ Million) Table 154. China Prostacyclin Revenue by Application (2027-2032) & (US$ Million) Table 155. China Prostacyclin Sales by Application (2021-2026) & (K Unit) Table 156. China Prostacyclin Sales by Application (2027-2032) & (K Unit) Table 157. China Prostacyclin Sales Price by Application (2021-2026) & (USD/Unit) Table 158. China Prostacyclin Sales Price by Application (2027-2032) & (USD/Unit) Table 159. Asia Prostacyclin Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Prostacyclin Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Prostacyclin Sales by Type (2021-2026) & (K Unit) Table 162. Asia Prostacyclin Sales by Type (2027-2032) & (K Unit) Table 163. Asia Prostacyclin Sales Price by Type (2021-2026) & (USD/Unit) Table 164. Asia Prostacyclin Sales Price by Type (2027-2032) & (USD/Unit) Table 165. Asia Prostacyclin Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Prostacyclin Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Prostacyclin Sales by Application (2021-2026) & (K Unit) Table 168. Asia Prostacyclin Sales by Application (2027-2032) & (K Unit) Table 169. Asia Prostacyclin Sales Price by Application (2021-2026) & (USD/Unit) Table 170. Asia Prostacyclin Sales Price by Application (2027-2032) & (USD/Unit) Table 171. Asia Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Prostacyclin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Prostacyclin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Prostacyclin Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 175. Asia Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 176. Asia Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 177. Asia Prostacyclin Sales Price by Country (2021-2026) & (USD/Unit) Table 178. Asia Prostacyclin Sales Price by Country (2027-2032) & (USD/Unit) Table 179. Japan Prostacyclin Revenue (2021-2032) & (US$ Million) Table 180. South Korea Prostacyclin Revenue (2021-2032) & (US$ Million) Table 181. India Prostacyclin Revenue (2021-2032) & (US$ Million) Table 182. Australia Prostacyclin Revenue (2021-2032) & (US$ Million) Table 183. Taiwan Prostacyclin Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Prostacyclin Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Prostacyclin Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Prostacyclin Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Prostacyclin Sales by Type (2021-2026) & (K Unit) Table 188. SAMEA Prostacyclin Sales by Type (2027-2032) & (K Unit) Table 189. SAMEA Prostacyclin Sales Price by Type (2021-2026) & (USD/Unit) Table 190. SAMEA Prostacyclin Sales Price by Type (2027-2032) & (USD/Unit) Table 191. SAMEA Prostacyclin Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Prostacyclin Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Prostacyclin Sales by Application (2021-2026) & (K Unit) Table 194. SAMEA Prostacyclin Sales by Application (2027-2032) & (K Unit) Table 195. SAMEA Prostacyclin Sales Price by Application (2021-2026) & (USD/Unit) Table 196. SAMEA Prostacyclin Sales Price by Application (2027-2032) & (USD/Unit) Table 197. SAMEA Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Prostacyclin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Prostacyclin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Prostacyclin Sales by Country (2021 VS 2025 VS 2032) & (K Unit) Table 201. SAMEA Prostacyclin Sales by Country (2021-2026) & (K Unit) Table 202. SAMEA Prostacyclin Sales by Country (2027-2032) & (K Unit) Table 203. SAMEA Prostacyclin Sales Price by Country (2021-2026) & (USD/Unit) Table 204. SAMEA Prostacyclin Sales Price by Country (2027-2032) & (USD/Unit) Table 205. Brazil Prostacyclin Revenue (2021-2032) & (US$ Million) Table 206. Argentina Prostacyclin Revenue (2021-2032) & (US$ Million) Table 207. Chile Prostacyclin Revenue (2021-2032) & (US$ Million) Table 208. Colombia Prostacyclin Revenue (2021-2032) & (US$ Million) Table 209. Peru Prostacyclin Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Prostacyclin Revenue (2021-2032) & (US$ Million) Table 211. Israel Prostacyclin Revenue (2021-2032) & (US$ Million) Table 212. UAE Prostacyclin Revenue (2021-2032) & (US$ Million) Table 213. Turkey Prostacyclin Revenue (2021-2032) & (US$ Million) Table 214. Iran Prostacyclin Revenue (2021-2032) & (US$ Million) Table 215. Egypt Prostacyclin Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Prostacyclin Distributors List Table 219. Prostacyclin Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Prostacyclin Image Figure 2. Global Prostacyclin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostacyclin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Epoprostenol Sodium Image Figure 5. Treprostinil Image Figure 6. Iloprost Image Figure 7. Beraprost Sodium Image Figure 8. Global Prostacyclin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Prostacyclin Market Size Share 2021 VS 2025 VS 2032 Figure 10. For Injection Image Figure 11. For Oral Image Figure 12. For Inhalation Image Figure 13. Global Prostacyclin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Prostacyclin Revenue (2021-2032) & (US$ Million) Figure 15. Global Prostacyclin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Prostacyclin Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Prostacyclin Revenue Market Share by Region (2021-2032) Figure 18. Global Prostacyclin Sales (2021-2032) & (K Unit) Figure 19. Global Prostacyclin Sales by Region: 2021 VS 2025 VS 2032 (K Unit) Figure 20. Global Prostacyclin Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Prostacyclin Sales YoY (2021-2032) & (K Unit) Figure 22. Europe Prostacyclin Sales YoY (2021-2032) & (K Unit) Figure 23. China Prostacyclin Sales YoY (2021-2032) & (K Unit) Figure 24. Asia (Excluding China) Prostacyclin Sales YoY (2021-2032) & (K Unit) Figure 25. South America, Middle East and Africa Prostacyclin Sales YoY (2021-2032) & (K Unit) Figure 26. Global Prostacyclin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Prostacyclin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Prostacyclin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Prostacyclin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Prostacyclin Revenue Market Share by Type (2021-2032) Figure 32. Global Prostacyclin Sales by Type (2021 VS 2025 VS 2032) & (K Unit) Figure 33. Global Prostacyclin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Prostacyclin Sales Market Share by Type (2021-2032) Figure 35. Global Prostacyclin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Prostacyclin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Prostacyclin Revenue Market Share by Application (2021-2032) Figure 38. Global Prostacyclin Sales by Application (2021 VS 2025 VS 2032) & (K Unit) Figure 39. Global Prostacyclin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Prostacyclin Sales Market Share by Application (2021-2032) Figure 41. North America Prostacyclin Revenue Share by Type (2021-2032) Figure 42. North America Prostacyclin Sales Share by Type (2021-2032) Figure 43. North America Prostacyclin Revenue Share by Application (2021-2032) Figure 44. North America Prostacyclin Sales Share by Application (2021-2032) Figure 45. North America Prostacyclin Revenue Share by Country (2021-2032) Figure 46. North America Prostacyclin Sales Share by Country (2021-2032) Figure 47. Europe Prostacyclin Revenue Share by Type (2021-2032) Figure 48. Europe Prostacyclin Sales Share by Type (2021-2032) Figure 49. Europe Prostacyclin Revenue Share by Application (2021-2032) Figure 50. Europe Prostacyclin Sales Share by Application (2021-2032) Figure 51. Europe Prostacyclin Revenue Share by Country (2021-2032) Figure 52. Europe Prostacyclin Sales Share by Country (2021-2032) Figure 53. China Prostacyclin Revenue Share by Type (2021-2032) Figure 54. China Prostacyclin Sales Share by Type (2021-2032) Figure 55. China Prostacyclin Revenue Share by Application (2021-2032) Figure 56. China Prostacyclin Sales Share by Application (2021-2032) Figure 57. Asia Prostacyclin Revenue Share by Type (2021-2032) Figure 58. Asia Prostacyclin Sales Share by Type (2021-2032) Figure 59. Asia Prostacyclin Revenue Share by Application (2021-2032) Figure 60. Asia Prostacyclin Sales Share by Application (2021-2032) Figure 61. Asia Prostacyclin Revenue Share by Country (2021-2032) Figure 62. Asia Prostacyclin Sales Share by Country (2021-2032) Figure 63. SAMEA Prostacyclin Revenue Share by Type (2021-2032) Figure 64. SAMEA Prostacyclin Sales Share by Type (2021-2032) Figure 65. SAMEA Prostacyclin Revenue Share by Application (2021-2032) Figure 66. SAMEA Prostacyclin Sales Share by Application (2021-2032) Figure 67. SAMEA Prostacyclin Revenue Share by Country (2021-2032) Figure 68. SAMEA Prostacyclin Sales Share by Country (2021-2032) Figure 69. Prostacyclin Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Prostacyclin Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Epoprostenol Sodium
  • Treprostinil
  • Iloprost
  • Beraprost Sodium
Applications
  • For Injection
  • For Oral
  • For Inhalation
Companies covered
  • United Therapeutics
  • Actelion (J & J)
  • GSK
  • Teva
  • Toray
  • Tide Pharma
  • Bayer AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prostacyclin Market by Type
  3. 1.2.1 Global Prostacyclin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Epoprostenol Sodium
  5. 1.2.3 Treprostinil
  6. 1.2.4 Iloprost
  7. 1.2.5 Beraprost Sodium
  8. 1.3 Prostacyclin Market by Application
  9. 1.3.1 Global Prostacyclin Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 For Injection
  11. 1.3.3 For Oral
  12. 1.3.4 For Inhalation
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Prostacyclin Market Dynamics
  1. 2.1 Prostacyclin Industry Trends
  2. 2.2 Prostacyclin Industry Drivers
  3. 2.3 Prostacyclin Industry Opportunities and Challenges
  4. 2.4 Prostacyclin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prostacyclin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prostacyclin Revenue by Region
  3. 3.2.1 Global Prostacyclin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prostacyclin Revenue by Region (2021-2026)
  5. 3.2.3 Global Prostacyclin Revenue by Region (2027-2032)
  6. 3.2.4 Global Prostacyclin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prostacyclin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prostacyclin Sales by Region
  9. 3.4.1 Global Prostacyclin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prostacyclin Sales by Region (2021-2026)
  11. 3.4.3 Global Prostacyclin Sales by Region (2027-2032)
  12. 3.4.4 Global Prostacyclin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prostacyclin Revenue by Manufacturers
  2. 4.1.1 Global Prostacyclin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prostacyclin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prostacyclin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prostacyclin Sales by Manufacturers
  6. 4.2.1 Global Prostacyclin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prostacyclin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prostacyclin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prostacyclin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prostacyclin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prostacyclin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prostacyclin Manufacturers, Product Type & Application
  13. 4.7 Global Prostacyclin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prostacyclin Market CR5 and HHI
  16. 4.8.2 2025 Prostacyclin Tier 1, Tier 2, and Tier 3
5 Prostacyclin Market by Type
  1. 5.1 Global Prostacyclin Revenue by Type
  2. 5.1.1 Global Prostacyclin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prostacyclin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prostacyclin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prostacyclin Sales by Type
  6. 5.2.1 Global Prostacyclin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostacyclin Sales by Type (2021-2032) & (K Unit)
  8. 5.2.3 Global Prostacyclin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prostacyclin Price by Type
6 Prostacyclin Market by Application
  1. 6.1 Global Prostacyclin Revenue by Application
  2. 6.1.1 Global Prostacyclin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prostacyclin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prostacyclin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prostacyclin Sales by Application
  6. 6.2.1 Global Prostacyclin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prostacyclin Sales by Application (2021-2032) & (K Unit)
  8. 6.2.3 Global Prostacyclin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prostacyclin Price by Application
7 Company Profiles
  1. 7.1 United Therapeutics
  2. 7.1.1 United Therapeutics Company Information
  3. 7.1.2 United Therapeutics Business Overview
  4. 7.1.3 United Therapeutics Prostacyclin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 United Therapeutics Prostacyclin Product Portfolio
  6. 7.1.5 United Therapeutics Recent Developments
  7. 7.2 Actelion (J & J)
  8. 7.2.1 Actelion (J & J) Company Information
  9. 7.2.2 Actelion (J & J) Business Overview
  10. 7.2.3 Actelion (J & J) Prostacyclin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Actelion (J & J) Prostacyclin Product Portfolio
  12. 7.2.5 Actelion (J & J) Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Prostacyclin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Prostacyclin Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Teva
  20. 7.4.1 Teva Company Information
  21. 7.4.2 Teva Business Overview
  22. 7.4.3 Teva Prostacyclin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Teva Prostacyclin Product Portfolio
  24. 7.4.5 Teva Recent Developments
  25. 7.5 Toray
  26. 7.5.1 Toray Company Information
  27. 7.5.2 Toray Business Overview
  28. 7.5.3 Toray Prostacyclin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Toray Prostacyclin Product Portfolio
  30. 7.5.5 Toray Recent Developments
  31. 7.6 Tide Pharma
  32. 7.6.1 Tide Pharma Company Information
  33. 7.6.2 Tide Pharma Business Overview
  34. 7.6.3 Tide Pharma Prostacyclin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tide Pharma Prostacyclin Product Portfolio
  36. 7.6.5 Tide Pharma Recent Developments
  37. 7.7 Bayer AG
  38. 7.7.1 Bayer AG Company Information
  39. 7.7.2 Bayer AG Business Overview
  40. 7.7.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bayer AG Prostacyclin Product Portfolio
  42. 7.7.5 Bayer AG Recent Developments
8 North America
  1. 8.1 North America Prostacyclin Market Size by Type
  2. 8.1.1 North America Prostacyclin Revenue by Type (2021-2032)
  3. 8.1.2 North America Prostacyclin Sales by Type (2021-2032)
  4. 8.1.3 North America Prostacyclin Price by Type (2021-2032)
  5. 8.2 North America Prostacyclin Market Size by Application
  6. 8.2.1 North America Prostacyclin Revenue by Application (2021-2032)
  7. 8.2.2 North America Prostacyclin Sales by Application (2021-2032)
  8. 8.2.3 North America Prostacyclin Price by Application (2021-2032)
  9. 8.3 North America Prostacyclin Market Size by Country
  10. 8.3.1 North America Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prostacyclin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prostacyclin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Prostacyclin Market Size by Type
  2. 9.1.1 Europe Prostacyclin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prostacyclin Sales by Type (2021-2032)
  4. 9.1.3 Europe Prostacyclin Price by Type (2021-2032)
  5. 9.2 Europe Prostacyclin Market Size by Application
  6. 9.2.1 Europe Prostacyclin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prostacyclin Sales by Application (2021-2032)
  8. 9.2.3 Europe Prostacyclin Price by Application (2021-2032)
  9. 9.3 Europe Prostacyclin Market Size by Country
  10. 9.3.1 Europe Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prostacyclin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prostacyclin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Prostacyclin Market Size by Type
  2. 10.1.1 China Prostacyclin Revenue by Type (2021-2032)
  3. 10.1.2 China Prostacyclin Sales by Type (2021-2032)
  4. 10.1.3 China Prostacyclin Price by Type (2021-2032)
  5. 10.2 China Prostacyclin Market Size by Application
  6. 10.2.1 China Prostacyclin Revenue by Application (2021-2032)
  7. 10.2.2 China Prostacyclin Sales by Application (2021-2032)
  8. 10.2.3 China Prostacyclin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prostacyclin Market Size by Type
  2. 11.1.1 Asia Prostacyclin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prostacyclin Sales by Type (2021-2032)
  4. 11.1.3 Asia Prostacyclin Price by Type (2021-2032)
  5. 11.2 Asia Prostacyclin Market Size by Application
  6. 11.2.1 Asia Prostacyclin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prostacyclin Sales by Application (2021-2032)
  8. 11.2.3 Asia Prostacyclin Price by Application (2021-2032)
  9. 11.3 Asia Prostacyclin Market Size by Country
  10. 11.3.1 Asia Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prostacyclin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prostacyclin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prostacyclin Market Size by Type
  2. 12.1.1 SAMEA Prostacyclin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prostacyclin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prostacyclin Price by Type (2021-2032)
  5. 12.2 SAMEA Prostacyclin Market Size by Application
  6. 12.2.1 SAMEA Prostacyclin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prostacyclin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prostacyclin Price by Application (2021-2032)
  9. 12.3 SAMEA Prostacyclin Market Size by Country
  10. 12.3.1 SAMEA Prostacyclin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prostacyclin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prostacyclin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prostacyclin Value Chain Analysis
  2. 13.1.1 Prostacyclin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prostacyclin Production Mode & Process
  6. 13.2 Prostacyclin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prostacyclin Distributors
  9. 13.2.3 Prostacyclin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst